The document discusses the importance of quantifying DNA damage in assessing the potential adverse effects of dermatological compounds, utilizing assays like γH2AX and the comet assay. It details the experimental approach involving various cell models, including HepG2 and primary human keratinocytes, to analyze DNA damage from genotoxic agents. Preliminary results indicate the effectiveness of high-content imaging technology in screening, albeit with suggestions for further validation and improvement of methodologies.